Cargando…
Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that is spreading rapidly, which seriously impacts global public health and economy. Thus, developing effective drugs remains urgent. We identify two potent antibodies, nCoVmab1 and nCoVmab2, targeting the SARS-CoV-2...
Autores principales: | Zhao, Shaojuan, Zhang, Huajun, Yang, Xinglou, Zhang, Haiwei, Chen, Ying, Zhan, Yancheng, Zhang, Xiaoqing, Jiang, Rendi, Liu, Meiqin, Liu, Lan, Chen, Li, Tang, Wei, Peng, Cheng, Gao, Xiaoxiao, Zhang, Zhe, Shi, Zhengli, Gong, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352940/ https://www.ncbi.nlm.nih.gov/pubmed/34373446 http://dx.doi.org/10.1038/s41467-021-25153-x |
Ejemplares similares
-
Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys
por: Wang, Shuang, et al.
Publicado: (2020) -
Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016) -
A potent neutralizing antibody provides protection against SARS-CoV-2 Omicron and Delta variants via nasal delivery
por: Zhang, Xinghai, et al.
Publicado: (2022) -
Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors
por: Fan, Pengfei, et al.
Publicado: (2020) -
A potent neutralizing nanobody against SARS‐CoV‐2 with inhaled delivery potential
por: Gai, Junwei, et al.
Publicado: (2021)